Thromboembolic disease and thrombocytopenia associated with the use of low-molecular weight heparins
Bóveda Treviño, J.L.; Gràcia Gozalo, R.M.; Barrabés, J.; Monasterio, J.
Medicina Clinica 96(18): 718-719
1991
ISSN/ISBN: 0025-7753 PMID: 1649359 Document Number: 382704
Document emailed within 1 workday
Related Documents
Tapson, V.F.; Hull, R.D. 1995: Management of venous thromboembolic disease. the impact of low-molecular-weight heparin Clinics in Chest Medicine 16(2): 281-294Fareed, J.; Hoppensteadt, D.; Jeske, W.; Clarizio, R.; Walenga, J.M. 1998: Low molecular weight heparins: are they different? Canadian Journal of Cardiology 14 Suppl E: 28e-34e
Ebell, M.H. 1994: Low molecular weight heparins for DVT Journal of Family Practice 39(5): 501-502
Agnelli, G.; Cosmi, B. 1990: Low molecular weight heparins Medicina 10(1): 9-15
Drouet, L. 1993: Low molecular weight heparins Presse Medicale 22(40): 2002-2008
Doutremepuich, C.; Puyal, C.; Lalanne, M.C.; Doutremepuich, F.; De Sèze, O. 1990: How to standardize low molecular weight heparins Annales de Biologie Clinique 48(4): 221-225
Hunt, D. 1998: Low-molecular-weight heparins in clinical practice Southern Medical Journal 91(1): 2-10
Mammen, E.F.; Arcelus, J.; Messmore, H.; Altman, R.; Nurmohamed, M.; Eldor, A. 1999: Clinical differentiation of low molecular weight heparins Seminars in Thrombosis and Hemostasis 25(Suppl 3): 135-144
Horellou, M.H.; Samama, M. 1991: Low molecular weight heparins in everyday practice Journal des Maladies Vasculaires 16(2): 179-183
Vignes, S.; Meyer, G.; Marjanovic, Z.; Farge-Bancel, D. 1997: Current indications of low-molecular-weight heparins Annales de Medecine Interne 148(2): 154-162
De Lorenzo, F.; Dotsenko, O.; Kakkar, V.V. 2005: Low molecular weight heparins in cardiovascular medicine Minerva Cardioangiologica 53(6): 585-603
Samama, M.M.; Michaut-Paterno, F. 1991: Therapeutic indications of low molecular weight heparins Archives des Maladies du Coeur et des Vaisseaux 84(11 Suppl): 1733-1743
Vermylen, J.G. 1993: Effect of heparin and low molecular weight heparins on platelets Seminars in Thrombosis and Hemostasis 19(Suppl 1): 20-21
Udvardy, M.; Rák, K. 2001: Comments about dosing of low molecular weight heparins (LMWH) Orvosi Hetilap 142(38): 2077-2082
Linhardt, R.J.; Gunay, N.S. 1999: Production and chemical processing of low molecular weight heparins Seminars in Thrombosis and Hemostasis 25(Suppl 3): 5-16
Ghali, W.A.; Pannatier, A.; Tsuyuki, R.T.; Hull, R.D.; MacKay, E.; Quan, H.; Cornuz, J. 2002: Transition from unfractionated heparin to low molecular weight heparins Thrombosis and Haemostasis 88(3): 539-540
Ramasamy, I.; Kennedy, J.; Tan, K. 2003: Capillary electrophoresis for characterization of low molecular weight heparins Laboratory Hematology: Official Publication of the International Society for Laboratory Hematology 9(2): 64-66
Jørgensen, L.N.; Wille-Jørgensen, P.A.; Hauch, O. 1994: Prevention of postoperative thrombosis with low-molecular-weight heparins Ugeskrift for Laeger 156(39): 5667-5672
Bergqvist, D. 1992: Review of clinical trials of low molecular weight heparins European Journal of Surgery 158(2): 67-78
Mismetti, P.; Laporte-Simitsidis, S.; Leizorovicz, A.; Decousus, H. 1997: Heparins and curative treatment of venous thromboembolic disease: meta-analysis Therapie 52(1): 47-52